Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study
Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Endocrine Surgery. Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden; Department of Diagnostics and Intervention, Oncology, Register Centre North, Umeå Universtity, Umeå, Sweden.ORCID iD: 0000-0001-6808-4405
Department of Translational Medicine, Lund University, Malmö, Sweden.
Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden.
Show others and affiliations
2025 (English)In: Frontiers in Oncology, E-ISSN 2234-943X, Vol. 15, article id 1680916Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Frontiers Media S.A., 2025. Vol. 15, article id 1680916
Keywords [en]
urinary bladder cancer, population based study, survival trends, metastatic disease, checkpoint inhibitors (ICIs)
National Category
Cancer and Oncology Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:uu:diva-570566DOI: 10.3389/fonc.2025.1680916ISI: 001595159600001PubMedID: 41114360Scopus ID: 2-s2.0-105018954960OAI: oai:DiVA.org:uu-570566DiVA, id: diva2:2010833
Funder
Swedish Cancer Society, CAN 2022/1971Swedish Cancer Society, CAN 2023/2807Available from: 2025-11-03 Created: 2025-11-03 Last updated: 2025-11-03Bibliographically approved

Open Access in DiVA

fulltext(795 kB)125 downloads
File information
File name FULLTEXT01.pdfFile size 795 kBChecksum SHA-512
58852bc96481fb078cfb9ef0f65509008db39170db5611a67dca158ad4b94d2c15457dfddb41534b00366e8e8944004bf391c55c9fa3aa7487fab2f838e52485
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Häggström, ChristelHolmberg, LarsMalmström, Per-Uno

Search in DiVA

By author/editor
Häggström, ChristelHolmberg, LarsMalmström, Per-Uno
By organisation
Endocrine SurgeryUppsala Clinical Research Center (UCR)Urology
In the same journal
Frontiers in Oncology
Cancer and OncologyPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 755 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.47.0
|
WCAG
|
Uppsala University Library
|
Ask the Library
|
Log in to DiVA
|
Search and link in DiVA